🇺🇸 FDA
Pipeline program

SPGL008

SPGL008-102

Phase 2 mab active

Quick answer

SPGL008 for NMIBC is a Phase 2 program (mab) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
NMIBC
Phase
Phase 2
Modality
mab
Status
active

Clinical trials